Gene · 4939
Papers2,192
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,192
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antiviral response and immunopathogenesis of interleukin 27 in COVID-19. | Arch Virol | 2023 | 37310504 | PubTator, text mining | PubMed |
| Rift Valley fever virus modulates apoptosis and immune response during infection of human astrocytes. | Emerg Microbes Infect | 2023 | 37306630 | PubTator, text mining | PubMed |
| SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness? | Int J Mol Sci | 2023 | 37298304 | PubTator, text mining | PubMed |
| Activation of cytosolic RNA sensors by endogenous ligands: roles in disease pathogenesis. | Front Immunol | 2023 | 37292201 | PubTator, text mining | PubMed |
| A Kaposi's sarcoma-associated herpes virus-encoded microRNA contributes to dilated cardiomyopathy. | Signal Transduct Target Ther | 2023 | 37291118 | PubTator, text mining | PubMed |
| Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity. | Hum Genomics | 2023 | 37287057 | PubTator, text mining | PubMed |
| Regionalization of the antiviral response in the gastrointestinal tract to provide spatially controlled host/pathogen interactions. | mBio | 2023 | 37260237 | PubTator, text mining | PubMed |
| Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection. | Immunity | 2023 | 37257450 | PubTator, text mining | PubMed |
| Establishment of sheep nasal mucosa explant model and its application in antiviral research. | Front Microbiol | 2023 | 37256060 | PubTator, text mining | PubMed |
| Accelerated replicative senescence of ataxia-telangiectasia skin fibroblasts is retained at physiologic oxygen levels, with unique and common transcriptional patterns. | Aging Cell | 2023 | 37254625 | PubTator, text mining | PubMed |
| The UHRF1 protein is a key regulator of retrotransposable elements and innate immune response to viral RNA in human cells. | Epigenetics | 2023 | 37246786 | PubTator, text mining | PubMed |
| DNA methyltransferase inhibitor 5-azacytidine enhances neuroblastoma cell lysis by an oncolytic parainfluenza virus. | Anticancer Drugs | 2023 | 37227036 | PubTator, text mining | PubMed |
| Comprehensive Analyses Reveal Effects on Tumor Immune Infiltration and Immunotherapy Response of APOBEC Mutagenesis and Its Molecular Mechanisms in Esophageal Squamous Cell Carcinoma. | Int J Biol Sci | 2023 | 37215984 | PubTator, text mining | PubMed |
| The predictive value of prognosis and therapeutic response for STAT family in pancreatic cancer. | Heliyon | 2023 | 37215832 | PubTator, text mining | PubMed |
| Transcriptome wide functional analysis of HBx expressing human hepatocytes stimulated with endothelial cell cross-talk. | Genomics | 2023 | 37209778 | PubTator, text mining | PubMed |
| Occludin Regulates HIV-1 Infection by Modulation of the Interferon Stimulated OAS Gene Family. | Mol Neurobiol | 2023 | 37209263 | PubTator, text mining | PubMed |
| Stress granules: potential therapeutic targets for infectious and inflammatory diseases. | Front Immunol | 2023 | 37205103 | PubTator, text mining | PubMed |
| Contribution to pathogenesis of accessory proteins of deadly human coronaviruses. | Front Cell Infect Microbiol | 2023 | 37197199 | PubTator, text mining | PubMed |
| Effects of Atherogenic Factors on Endothelial Cells: Bioinformatics Analysis of Differentially Expressed Genes and Signaling Pathways. | Biomedicines | 2023 | 37189834 | PubTator, text mining | PubMed |
| Down-regulation of DNA key protein-FEN1 inhibits OSCC growth by affecting immunosuppressive phenotypes via IFN-γ/JAK/STAT-1. | Int J Oral Sci | 2023 | 37185662 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4939/papers?page=14